INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c

INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion